Centene Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion.

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth prospects during the specified Class Period from December 12, 2024, to June 30, 2025 [1][4]. Company Overview - Centene Corporation is a healthcare enterprise that provides integrated services to government-sponsored and commercial healthcare programs, focusing on underinsured and uninsured individuals [3]. Allegations and Misleading Information - The lawsuit claims that Centene misled investors by presenting a false impression of reliable information concerning its projected revenue and growth, emphasizing strong enrollment rates and low morbidity levels [4]. - Contrary to these claims, the complaint alleges that there were adverse enrollment trends and worsening morbidity rates that were concealed from investors [5]. Financial Guidance and Market Performance - On July 1, 2025, Centene withdrew its 2025 guidance, revealing disappointing findings from its analysis of the Health Insurance Marketplace, with market growth across 22 states being significantly below expectations [6]. - The revised guidance indicated earnings of approximately $1.8 billion, translating to an adjusted diluted EPS of $2.75 [6]. Stock Price Impact - Following the announcement of the revised guidance, Centene's stock price dropped by over 40%, resulting in substantial financial losses for investors and leading to the current class action litigation [7].